MMAE&MMAF Monoclonal Antibody
Catalogue Number: CSB-MA903890I1M-CSB
CSB-MA903890I1M Image
CSB-MA903890I1M Image
CSB-MA903890I1M Image
CSB-MA903890I1M Image
CSB-MA903890I1M Image
MMAE&MMAF antibody on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 90%.
CSB-MA903890I1M Image
The Binding Activity of Disitamab vedotin (Synonyms: RC48) with Anti-MMAE&MMAF antibody Activity: Measured by its binding ability in a functional ELISA. Immobilized Disitamab vedotin (Synonyms: RC48) at 2 µg/mL can bind Anti-MMAE&MMAF antibody, the EC50 is 1.908 to 2.492 ng/mL.
CSB-MA903890I1M Image
The Binding Activity of Depatuxizumab mafodotin (Synonyms: ABT-414) with Anti-MMAE&MMAF antibody Activity: Measured by its binding ability in a functional ELISA. Immobilized Depatuxizumab mafodotin (Synonyms: ABT-414) at 2 µg/mL can bind Anti-MMAE&MMAF antibody, the EC50 is 1.927 to 3.280 ng/mL.
CSB-MA903890I1M Image
The Binding Activity of Disitamab vedotin (Synonyms: RC48) and Depatuxizumab mafodotin (Synonyms: ABT-414) with Anti-MMAE&MMAF antibody Activity: Measured by its binding ability in a functional ELISA. Immobilized Disitamab vedotin (Synonyms: RC48) and Depatuxizumab mafodotin (Synonyms: ABT-414) at 2 µg/mL can bind Anti-MMAE&MMAF antibody, the EC50 is 1.908 to 2.492 ng/mL and 1.927 to 3.280 ng/mL, respectively.
| Manufacturer: | Cusabio Biotech |
| Preservative: | 0.03% ProClin™ 300 |
| Physical state: | Liquid |
| Type: | Monoclonal Primary Antibody - Unconjugated |
| Alias: | MMAE, Monomethyl auristatin E, SGD-1010, Vedotin; MMAF, Monomethylauristatin F |
| Shipping Condition: | Blue Ice |
| Unit(s): | 100 ul, 50 ul |
| Host name: | Mouse |
| Clone: | 25G12B5 |
| Isotype: | IgG2b |
| Immunogen: | MMAE-BSA |
| Application: | ELISA |
Additional Text
Purification
Protein G purified
Storage Note
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Antibody Clonality
Monoclonal
SUPPORT
outstanding technical support
PRODUCT
we offer a full product guarantee
DELIVERY
we offer free delivery to UK universities and non profit organisations